DBV Technologies S.A. - DBVT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G | MPM BioImpact LLC | 9.9% | 24,579,307 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners II, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings II, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management II, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Nimish Shah | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Advisors LLC | 3.1% | 7,413,959 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Advisors Holdings LP | 3.1% | 7,413,959 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel GP LLC | 3.1% | 7,413,959 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Securities LLC | 0.0% | 47,240 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Securities Group LP | 0.3% | 732,551 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Securities GP LLC | 0.3% | 732,551 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Kenneth Griffin | 3.5% | 8,146,510 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 5.6% | 13,038,825 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 5.6% | 13,038,825 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Global Management, LLC | 5.6% | 13,038,825 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Siren, L.L.C. | 5.6% | 13,038,825 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master Fund LP | 0.6% | 1,312,135 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master GP LLC | 0.6% | 1,312,135 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Ulys, L.L.C. | 0.6% | 1,312,135 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Raymond Debbane | 6.2% | 14,350,960 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Vivo Opportunity Fund Holdings, L.P. | 5.7% | 15,685,950 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Vivo Opportunity, LLC | 5.7% | 15,685,950 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Vivo Opportunity Cayman Fund, L.P. | 0.7% | 2,014,280 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Vivo Opportunity Cayman, LLC | 0.7% | 2,014,280 | View |
| Feb 03, 2026 | SCHEDULE 13G | Artisan Partners Asset Management Inc. | 7.0% | 3,309,055 | View |
| Feb 03, 2026 | SCHEDULE 13G | Artisan Partners Holdings LP | 7.0% | 3,309,055 | View |
| Feb 03, 2026 | SCHEDULE 13G | Artisan Investments GP LLC | 7.0% | 3,309,055 | View |
| Feb 03, 2026 | SCHEDULE 13G | Artisan Partners Limited Partnership | 7.0% | 3,309,055 | View |
| Jan 14, 2026 | SCHEDULE 13D/A | — | 9.99% | 2,104,027 | View |
| Jan 08, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 8.8% | 20,469,392 | View |
| Jan 07, 2026 | SCHEDULE 13D/A | — | 5.0% | 232,047,938 | View |
| Jan 05, 2026 | SCHEDULE 13D/A | — | 5.2% | 200,618,067 | View |
| Dec 19, 2025 | SCHEDULE 13D/A | — | 6.7% | 200,618,067 | View |
| Dec 12, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 2.6% | 5,272,532 | View |
| Dec 08, 2025 | SCHEDULE 13G | JANUS HENDERSON GROUP PLC | 9.5% | 20,469,392 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners II, L.P. | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Co-Investment Holdings II, LLC | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management II, LLC | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management III, LLC | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management EG, LLC | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nimish Shah | 8.2% | 11,929,079 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Bong Y. Koh | 8.2% | 11,929,079 | View |
| Nov 04, 2025 | SCHEDULE 13D/A | — | 9.2% | 179,827,919 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.